Login / Signup

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Giovanni CaocciGiorgio La Nasa
Published in: Annals of hematology (2020)
Keyphrases
  • acute respiratory distress syndrome
  • extracorporeal membrane oxygenation
  • mechanical ventilation